Greenbrook TMS

+$0.19 (+8.09%) Today

-$0.01 (-0.39%) As of 8:00 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Greenbrook TMS and other ETFs, options, and stocks.

About GBNH

Greenbrook Tms, Inc. engages in the provision of transcranial magnetic stimulation, an FDA-cleared, non-invasive therapy for the treatment of major depressive disorder. The company was founded on February 9, 2018 and is headquartered in Toronto, Canada.

CEO

William P. Leonard

Employees

430

Headquarters

Toronto, Ontario

Founded

2018

GBNH Key Statistics

Market cap

Price-Earnings ratio

—

Dividend yield

—

Average volume

8.04K

High today

$2.54

Low today

$2.37

Open price

$2.37

Volume

3.42K

52 Week high

$13.76

52 Week low

$2.03

GBNH Earnings

-$0.48

-$0.32

-$0.16

$0.00

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Estimated

-$0.38 per share

Actual

-$0.44 per share

Why Robinhood?

Greenbrook Tms, Inc. engages in the provision of transcranial magnetic stimulation, an FDA-cleared, non-invasive therapy for the treatment of major depressive disorder. The company was founded on February 9, 2018 and is headquartered in Toronto, Canada. View more

Greenbrook Tms, Inc. engages in the provision of transcranial magnetic stimulation, an FDA-cleared, non-invasive therapy for the treatment of major depressive disorder. The company was founded on February 9, 2018 and is headquartered in Toronto, Canada.